Cell Applications Introduces Cellular Disease Model for Type 2 Diabetes
Reporter: Evelina B. Cohn, PhD
Press release on December 11, 2015
Cell Application Inc. Company announces on December 11, 2015 the design of human cellular disease model for Type 2 Diabetes. The product grouping consists of human aortic endothelial cells, aortic smooth muscle cells, preadipocytes and skeletal muscle isolated from patient donors affected with the disease.. In addition to high blood sugar 1 in 10 affected individuals encounter complications including high blood pressure, cholesterol, heart attack, stroke, blindness, kidney disease, pregnancy problems, amputation and in severe cases death. This model provides new primary cell based options for life sciences and pharmaceutical drug discovery. The company indicates that additional disease models can be generated on a custom service bases.
VIEW VIDEO
SOURCE
https://www.cellapplications.com/new-diabetes-cell-models#sthash.EcPyBxPO.dpuf
2012pharmaceutical
Amandeep Kaur
Aashir Awan, Phd
Abhisar Anand
Adina Hazan
Alan F. Kaul, PharmD., MS, MBA, FCCP
alexcrystal6
anamikasarkar
apreconasia
aviralvatsa
David Orchard-Webb, PhD
danutdaagmailcom
Demet Sag, Ph.D., CRA, GCP
Daniel Menzin
Dror Nir
dsmolyar
Ethan Coomber
evelinacohn
Gail S Thornton
Irina Robu
jayzmit48
jdpmd
jshertok
kellyperlman
Ed Kislauskis
komal23ingle
larryhbern
Madison Davis
marzankhan
megbaker58
ofermar2020
Dr. Pati
pkandala
Rosalind Codrington, PhD
ritusaxena
Rick Mandahl
satwik Sunnam
sjwilliamspa
Srinivas Sriram
stuartlpbi
Dr. Sudipta Saha
tildabarliya
vaishnavee24
zraviv06
zs22
I believe this is just cells which were isolated from patients and not a therapeutic
Thank you for your comment. It is possible. Then, why they are saying: is a model for type 2 diabetes? Are all the cells involved or not in this model? It looks like they are I have to find out somehow. what is the link between these cells in order to have them as a type 2 diabetes model.